All Stories

Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates

Insilico also disclosed it’s begun chasing new therapeutic areas in obesity and muscle wasting conditions as well as in nonaddictive painkillers.

Feb 11, 2025 - 15:05
 0
Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates
Insilico also disclosed it’s begun chasing new therapeutic areas in obesity and muscle wasting conditions as well as in nonaddictive painkillers.
Read More

Tags:

Previous Article

2026 Honda Passport Muscles Its Way Into Dealerships With A Starting MSRP Of $46...

Next Article

Compass makes push away from MLS to off-market listings

Related Posts

Heart monitoring patch maker VitalConnect raises $100M

Heart monitoring patch maker VitalConnect raises $100M

Feb 20, 2025  0

Fierce Biotech Layoff Tracker 2025: Q32 Bio restructures; Viracta shuts down

Fierce Biotech Layoff Tracker 2025: Q32 Bio restructure...

Feb 10, 2025  0

Basilea opts not to take MRSA antibiotic into clinic due to 'stringent risk-return criteria'

Basilea opts not to take MRSA antibiotic into clinic du...

Feb 18, 2025  0